FDA pharmacologic class
Isocitrate Dehydrogenase 2 Inhibitor
2 medicines are in FDA's class of isocitrate dehydrogenase 2 inhibitors: enasidenib (Idhifa) and vorasidenib (Voranigo). 0 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are isocitrate dehydrogenase 2 inhibitor?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Enasidenib | Idhifa | none listed | n/a | Yes | No current entry | 0 |
| Vorasidenib | Voranigo | none listed | n/a | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)